Warning letter
Innovations for Access, Inc., dba HemoBand Inc.: warning letter of Mar 10, 2008
FDA warning letter UCM1048376 · Seattle District Office
Key facts
| Reference number | UCM1048376 |
|---|---|
| Company | Innovations for Access, Inc., dba HemoBand Inc. |
| Subject | Premarket Approval/Misbranded/Adulterated |
| Issue date | Mar 10, 2008 |
| Posted date | Mar 10, 2008 |
| Issuing office | Seattle District Office |
| Product type | Devices |
| CFR sections cited | 820, 807.81(b) |
| Country | 3 |
| Inspection city | Beaverton |
| Inspection ZIP | 97006-7363 |
| Inspection start date | Sep 25, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: